John P. Hamill, SrVP/CFO/Prin Fin & Acct Ofcr: Aprea Therapeutics APRE Buy · Filed 24/03/14

Trade details

Type: Insider buy
Amount: $7,362.9
Shares · price: 1,010 sh · $7.29 a share
Held after: 15,503 sh
Stock: Aprea Therapeutics APRE
Person: John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
Trade date: 24/03/13
Filed: 24/03/14
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +7.0%

Aprea Therapeutics trades, last 26 weeks

What else happened in Aprea Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/12~24/04/12

John P. Hamill's recent trades

John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$5,073
5,700 sh
$5,073
Filed 02/02
Traded 01/30
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$5,850
5,000 sh
$5,850
Filed 25/12/11
Traded 25/12/10
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$123
50 sh
$123
Filed 24/10/16
Traded 24/10/11
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$1,175
450 sh
$1,175
Filed 24/10/15
Traded 24/10/10